Abstract:Abstract Background Probiotic might have a role in the prevention of ventilator-associated pneumonia (VAP) among mechanically ventilated patients, but the efficacy and safety remained inconsistent. The aim of this systematic review and meta-analysis was to evaluate the efficacy and safety of probiotic (prebiotic, synbiotic) versus placebo in preventing VAP in critically ill patients undergoing mechanical ventilation. Methods PubMed, Embase and the Cochrane library databases were searched to 10 October 2021 without language restriction for randomized or semi-randomized controlled trials evaluating probiotic (prebiotic, synbiotic) vs. placebo in prevention of VAP in critically ill mechanically ventilated patients. The pooled relative risk (RR) along with 95% confidence intervals (CI) were combined using a random-effects model. Furthermore, the trial sequential analysis (TSA) and subgroup analyses were performed. Statistical significance was regarded as P < 0.05. Results Twenty-three trials involving 5543 patients were eligible for this meta-analysis. The combined RR of decreasing the risk of VAP by probiotic was 0.67 (0.56, 0.81) for all eligible studies, 0.69 (n = 5136; 95% CI = 0.57 to 0.84; P < 0.01) for adults studies and 0.55 (n = 407; 95%CI = 0.31 to 0.99; P = 0.046) for neonates/children studies. Additionally, the above-mentioned positive finding in 20 adults studies was verified by the results of TSA, subgroup analyses and cumulative meta-analysis. Ample evidences demonstrated a 31% decrease in RR of incidence of VAP was noted when prophylactic probiotic therapy was administrated among adult patients. Finally, there were no effects on the ICU/hospital/28-/90-day mortality, bacteremia, CRBSI, diarrhea, ICU-acquired infections, infectious complications, pneumonia, UTI and wound infection between two groups ( P > 0.05 for all). Conclusions Based on the results of our study, the current evidences suggested that prophylactic administration of probiotic might be utilized as a preventive method for VAP in neonates/children and adults patients who required mechanical ventilation. However, further large, high-quality RCTs are warranted to assess the efficacy and safety of probiotic treatment in critically ill patients, especially for the neonates/children studies and the long-term consequences of this therapy.

Lower Respiratory Tract Microbial Composition Was Diversified in Pseudomonas Aeruginosa Ventilator-Associated Pneumonia Patients

Impact Clinically Related Factors on the Outcomes of Ventilator-Associated Pneumonia

Do Probiotics Help Prevent Ventilator-Associated Pneumonia In Critically Ill Patients? A Systematic Review With Meta-Analysis

[Research progress on the role of respiratory microbiome in ventilator-associated pneumonia]

Probiotics For Preventing Ventilator-Associated Pneumonia: A Systematic Review And Meta-Analysis Of High-Quality Randomized Controlled Trials

Analysis of the risk factors and pathogenic bacteria of ventilator-associated pneumonia

The Lower Respiratory Tract Microbiome in Pediatric Patients with Ventilator-Associated Pneumonia

Prospective study of colonization and infection because of Pseudomonas aeruginosa in mechanically ventilated patients at a neonatal intensive care unit in China.

Probiotics for the Prevention of Ventilator-Associated Pneumonia: A Meta-Analysis of Randomized Controlled Trials

Risk Factors for Lower Airway Bacteria Colonization and Ventilator-Associated Pneumonia in Mechanically Ventilated Patients

Probiotics for Preventing Ventilator-Associated Pneumonia in Mechanically Ventilated Patients: A Meta-Analysis with Trial Sequential Analysis.

Prevention of ventilator-associated pneumonia with probiotics: an overview of systematic reviews

Probiotic in the prevention of ventilator-associated pneumonia in critically ill patients: evidence from meta-analysis and trial sequential analysis of randomized clinical trials

Pathogenic analysis of sputum from ventilator-associated pneumonia in a pediatric intensive care unit.

Analysis of Microbial Pathogen and Therapeutic Mode of Ventilator-Associated Pneumonia in Patients with Chronic Obstructive Lung Disease

Risk factors in patients with Acinetobacter baumanii ventilator-associated pneumonia

Risk factors and peripheral blood lymphocyte subset analysis of patients with ventilator-associated pneumonia: a Chinese population-based study

[The Role of Gastro-Intestinal Tract Microorganisms in the Development of Ventilator-Associated Pneumonia: an Experimental Study].

Effect of mixed probiotics on pulmonary flora in patients with mechanical ventilation: an exploratory randomized intervention study

Airway Acidification Impaired Host Defense Against Pseudomonas Aeruginosa Infection by Promoting Type 1 Interferon Β Response

Carbapenem-resistant Acinetobacter Baumannii Ventilator-Associated Pneumonia in Critically Ill Patients: Potential Inference with Respiratory Tract Microbiota Dysbiosis